Vol. 6 No. 1 (2001)
Reflections

Are Placebo-Controlled Studies Ethical in Psychiatric Research?

PDF
  • Eric Cadesky
DOI: https://doi.org/10.26443/mjm.v6i1.764

Published 2001-06-01

Keywords

  • psychiatry,
  • placebo,
  • ethics

How to Cite

1.
Cadesky E. Are Placebo-Controlled Studies Ethical in Psychiatric Research?. McGill J Med [Internet]. 2001 Jun. 1 [cited 2025 Oct. 5];6(1):56-60. Available from: https://mjm.mcgill.ca/article/view/764

Copyright (c) 2020 Eric Cadesky

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Crossref
Scopus
Google Scholar
Europe PMC

Abstract

N/A

PDF

Downloads

Download data is not yet available.

References

  1. Devinsky O, Fisher R. Ethical use of placebos and provocative testing in diagnosing nonepileptic seizures. Neurology 1994; 47: 866-870.
  2. Quitkin FM. Placebos, effects, and study design: a clinician’s guide. American Journal of Psychiatry 1999; 156: 829-836.
  3. United States Food and Drug Administration. Testing drugs in people.
  4. http://www.fda.gov/cder/about/whatwedo/testtube-
  5. a.pdf. 2000.
  6. Medical Research Council. Tri-Council Policy Statement: Ethical conduct for research involving humans.
  7. http://www.nserc.ca/programs/ethics/english/policy.htm#contents. 2000
  8. Freedman B, Weijer C, Cranley Glass K. Placebo orthodoxy in clinical research II: ethical, legal, and regulatory myths. Journal of Law, Medicine & Ethics 1996b; 24: 252-259.
  9. Freedman B, Weijer C, Cranley Glass K. Placebo orthodoxy in clinical research I: empirical and methodological myths.
  10. Journal of Law, Medicine & Ethics 1996a; 24: 243-251.
  11. Elliott C, Weijer C. Cruel and unusual treatment. Saturday Night 1995; December: 31-34.
  12. Beauchamp TL, Childress, JF. Principles of biomedical ethics. 4th Ed. New York: Oxford University Press; 1994.
  13. 48th World Medical Association General Assembly. Declaration of Helsinki, 5th revision. Somerset West, South
  14. Africa; 1996
  15. Malette vs. Shulman (Ont. C.A.)72 O.R.(2d) 417, [1990] O.J. No.450.
  16. Malone RP, Simpson GM. Use of placebos in clinical trials involving children and adolescents. Psychiatric Services 1998;
  17. : 1413-1414.
  18. Ney PG, Collins C, Spensor C. Double blind: double talk or are there ways better to do better research? Medical Hypotheses 1986; 21: 119-126.
  19. Molcho A, Stanley M. Antidepressants and suicide risk: issues of chemical and behavioral toxicity. Journal of Clinical
  20. Psychopharmacology 1992; 12 (suppl.): 13S-18S.
  21. Addington D, Williams R, Lapierre Y, el-Giebaly N. Placebos in clinical trials of psychotropic medication. Canadian Journal of Psychiatry 1997; 42: 6pp insert.
  22. Kane JM. Tardive dyskinesia: epidemiological and clinical presentation. In: Bloom F, Kupfer DJ, eds.
  23. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995: 1485-1495.
  24. Fisher RL, Fisher S. Antidepressants for children: is scientific support necessary? Journal of Nervous and Mental Disease
  25. ; 184: 99-102.
  26. Burack JH, Back AL, Pearlman RA. Provoking nonepileptic seizures: the ethics of deceptive diagnostic testing. Hastings
  27. Center Report 1997; 27: 24-33.
  28. Appelbaum PS. Rethinking the conduct of psychiatric research. Archives of General Psychiatry 1997; 54: 117-120.